Last updated: April 23, 2026
Who supplies clobazam API?
Clobazam is supplied globally by both specialty generic API players and regional bulk-manufacturing specialists. The most consistently sourced API comes from established generic API plants serving global markets (US/EU) and from captive or contract manufacturing networks that support benzodiazepine product lines.
Because supplier lists are frequently time-sensitive and product-name variants exist across catalogs (e.g., “clobazam,” “clobazam BP/EP/USP”), procurement teams typically validate suppliers using three checkpoints: (1) API grade spec coverage (USP/EP/BP where applicable), (2) regulatory dossier support (DMF/ASMF availability where used), and (3) manufacturing controls for a controlled benzodiazepine substance.
What supplier archetypes dominate clobazam sourcing?
Clobazam supply typically falls into four supplier archetypes:
-
Generic API manufacturers (third-party)
- Supply clobazam API to multiple finished-dosage manufacturers across geographies.
- Commonly support DMF/ASMF-style documentation for regulated markets.
-
Contract Development and Manufacturing Organizations (CDMOs)
- Provide API-to-finished dosage services under development or commercial scale.
- Often bundled with analytical method transfer and stability packages.
-
Finished-dosage manufacturers (tablets)
- Supply the branded or generic tablet (oral) product directly.
- API sourcing may be internal or third-party.
-
Regional distribution partners
- Do not always manufacture API; they intermediate supply and logistics for controlled substances.
- Useful for shorter procurement cycles in local markets, subject to licensing.
Which document and spec criteria do buyers use for clobazam?
Procurement for clobazam API and finished products typically hinges on whether the supplier can meet the buyer’s regulatory and quality framework. The criteria that most affect supplier qualification are:
- Pharmacopeial alignment: clobazam API tested to a recognized standard (USP/EP/BP, as required by the dossier).
- Release testing package: identity, assay, impurities profile, and water/solvent criteria as applicable to the API route and spec.
- Genotoxic impurity controls: benzodiazepines are screened under modern impurity expectations; suppliers must provide data on impurity risk and control strategy.
- Controlled-substance handling: secure manufacturing, storage, and supply chain compliance for benzodiazepines.
- Regulatory support: DMF/ASMF availability (where used by the buyer), batch history, and site qualification documentation.
What is the finished-dosage supplier pattern for clobazam tablets?
For clobazam oral tablets (and liquid forms in certain markets), finished-dosage supply is usually concentrated among:
- Global generic firms that run centralized manufacturing networks.
- Regional specialists that focus on specific strength portfolios and local regulatory submissions.
- Niche benzodiazepine product operators that maintain development lines for CNS-controlled medicines.
In commercial practice, finished-dosage manufacturers often qualify 2 to 4 API sources to manage supply risk and controlled-substance continuity.
Where do buyers typically find clobazam supplier lists?
Supplier discovery for clobazam is generally done via:
- Regulatory filings and dossier references (e.g., ASMF/DMF when buyer dossiers reference an API manufacturer).
- Pharmacopeial and regulatory site listings used in internal vendor qualification.
- Procurement databases maintained by pharma supply-chain groups (these can include “API supplier,” “finished dosage supplier,” and “local distributor” categories).
What strengths and dosage forms drive supplier selection?
Supplier qualification depends on the target market portfolio:
- Tablets: strength-specific manufacturing capability (e.g., 5 mg, 10 mg, 20 mg in many markets).
- Oral suspensions / drops: if targeted, the supplier must support formulation, stability, and unit-dose packaging and shelf-life requirements.
- Packaging: child-resistant packaging is often requested for controlled CNS products.
Supplier shortlisting template (used in clobazam vendor qualification)
Buyers usually screen clobazam suppliers against the same qualification gates, then narrow to a small approved set:
- Manufacturing site eligibility
- GMP certificate coverage for the relevant dosage form or API scope.
- Product/grade match
- Exact clobazam API grade and relevant standards (USP/EP/BP) or buyer’s internal spec.
- Regulatory document access
- DMF/ASMF readiness or dossier support for the buyer’s submission strategy.
- Batch supply continuity
- Demonstrated ability to supply consistent purity and impurities over multiple batches.
- Controlled-substance supply chain
- Licensed handling and traceable logistics for benzodiazepines.
- Stability and analytical package
- Provided method transfer readiness and stability protocol history.
Key Takeaways
- Clobazam supply is dominated by qualified generic API manufacturers and CNS-focused finished-dosage operators, with CDMOs supporting scale-up and dossier execution.
- Supplier qualification for clobazam hinges on pharmacopeial alignment, impurity and analytical controls, and controlled-substance handling capability.
- Finished-dosage sourcing typically qualifies multiple API sources to manage supply risk and ensure continuity for controlled benzodiazepines.
- Procurement discovery is most reliable through regulatory dossier references and structured vendor qualification frameworks rather than marketing catalog claims.
FAQs
1) Is clobazam API commonly supplied through DMF/ASMF references?
Yes. Buyers often rely on DMF/ASMF-style documentation workflows for API site qualification and dossier alignment in regulated markets.
2) Do clobazam suppliers vary by API grade or pharmacopeia?
Yes. Suppliers can offer different grade/spec alignments (USP/EP/BP or internal specifications). Qualification is strength- and market-specific.
3) Can a finished-dosage manufacturer supply clobazam directly without disclosing the API source?
In many contracting models, API provenance can be described at the dossier level even if commercial supply chains remain partially internal. Buyers qualify API through dossier and quality systems.
4) What matters more for clobazam than general small-molecule API procurement?
Controlled-substance handling, secure logistics, and impurity control expectations for benzodiazepines tend to dominate the qualification process.
5) Are clobazam suppliers interchangeable across different dosage forms?
No. API suppliers may be separate from tablet or suspension manufacturers, and dosage-form capabilities depend on formulation and packaging readiness for regulated markets.
Sources (APA)
[1] USP. (n.d.). Clobazam monograph and related official information. United States Pharmacopeia.
[2] European Pharmacopoeia. (n.d.). Clobazam reference standard/monograph information. European Directorate for the Quality of Medicines & HealthCare (EDQM).
[3] FDA. (n.d.). Drug Master Files (DMF) and regulatory guidance overview. U.S. Food and Drug Administration.
